Biomarkers for Chimeric Antigen Receptor T Cell Therapy in Acute Lymphoblastic Leukemia: Prospects for Personalized Management and Prognostic Prediction

por Hong, Ruimin, Hu, Yongxian, Huang, He
Publicado 2021

Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy

por Hong, Ruimin, Zhao, Houli, Wang, Yiyun, Chen, Yu, Cai, Hongliu, Hu, Yongxian, Wei, Guoqing, Huang, He
Publicado 2020

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

por Hong, Ruimin, Zhao, Houli, Wang, Yiyun, Chen, Yu, Cai, Hongliu, Hu, Yongxian, Wei, Guoqing, Huang, He
Publicado 2020

Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment

por Zhou, Linghui, Zhao, Houli, Shao, Yang, Chen, Xin, Hong, Ruimin, Wang, Linqin, Ni, Fang, Nagler, Arnon, Hu, Yongxian, Huang, He
Publicado 2021

A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukem...

por Wang, Yiyun, Yang, Yingying, Hong, Ruimin, Zhao, Houli, Wei, Guoqing, Wu, Wenjun, Xu, Huijun, Cui, Jiazhen, Zhang, Yanlei, Chang, Alex H., Hu, Yongxian, Huang, He
Publicado 2020

New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

por Wang, Linqin, Hong, Ruimin, Zhou, Linghui, Ni, Fang, Zhang, Mingming, Zhao, Houli, Wu, Wenjun, Wang, Yiyun, Ding, Shuyi, Chang, Alex H., Hu, Yongxian, Huang, He
Publicado 2021

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission

por Wang, Yiyun, Wang, Linqin, Zeng, Yifan, Hong, Ruimin, Zu, Cheng, Yin, Elaine Tan Su, Zhao, Houli, Wei, Guoqing, Yang, Li, Jin, Aiyun, Hu, Yongxian, Huang, He
Publicado 2021

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma

por Xu, Xueer, Zu, Cheng, Zhang, Mingming, Xiao, Pingnan, Hong, Ruimin, Feng, Jingjing, Xu, Huijun, Cui, Jiazhen, Yu, Jian, Shi, Jimin, Wei, Guoqing, Chang, Alex H., Huang, He, Hu, Yongxian
Publicado 2023

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

por Ding, Lijuan, Wang, Yiyun, Hong, Ruimin, Zhao, Houli, Zhou, Linghui, Wei, Guoqing, Wu, Wenjun, Xu, Huijun, Zhang, Yanlei, Luo, Yi, Shi, Jimin, Chang, Alex H., Hu, Yongxian, Huang, He
Publicado 2021

Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-hum...

por Hu, Yongxian, Zu, Cheng, Zhang, Mingming, Wei, Guoqing, Li, Wei, Fu, Shan, Hong, Ruimin, Zhou, Linghui, Wu, Wenjun, Cui, Jiazhen, Wang, Dongrui, Du, Bing, Liu, Mingyao, Zhang, Jiqin, Huang, He
Publicado 2023

Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma

por Hong, Ruimin, Tan Su Yin, Elaine, Wang, Linqin, Zhao, Xin, Zhou, Linghui, Wang, Guangfa, Zhang, Mingming, Zhao, Houli, Wei, Guoqing, Wang, Yiyun, Wu, Wenjun, Zhang, Yafei, Ni, Fang, Hu, Yongxian, Huang, He, Zhao, Kui
Publicado 2021

Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy

por Zhang, Mingming, Zhou, Linghui, Zhao, Houli, Zhang, Yanlei, Wei, Guoqing, Hong, Ruimin, Wu, Wenjun, Xu, Huijun, Wang, Linqin, Ni, Fang, Cui, Jiazhen, Peng, Shuixiu, Huang, Chih-Hua, Chang, Alex H., Hu, Yongxian, Huang, He
Publicado 2021

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

por Hu, Yongxian, Li, Jingjing, Ni, Fang, Yang, Zhongli, Gui, Xiaohua, Bao, Zhiwei, Zhao, Houli, Wei, Guoqing, Wang, Yiyun, Zhang, Mingming, Hong, Ruimin, Wang, Linqin, Wu, Wenjun, Mohty, Mohamad, Nagler, Arnon, Chang, Alex H., van den Brink, Marcel R. M., Li, Ming D., Huang, He
Publicado 2022